FDA 批准了第一个无需药物即可减少关节炎炎症的电刺激设备。 FDA approves first electrical stimulation device to reduce arthritis inflammation without drugs.

美国食品和药品管理局批准了一种新装置,利用电刺激来减少风湿类关节炎患者的炎症,提供一种非药物治疗选择。 The U.S. Food and Drug Administration has approved a new device that uses electrical stimulation to reduce inflammation in people with rheumatoid arthritis, offering a non-drug treatment option. 这种创新为那些对传统药物反应不佳的病人提供了潜在的替代方案,标志着在管理慢性自免疫症方面迈出了重要一步。 This innovation provides a potential alternative for patients who don’t respond well to traditional medications, marking a significant step in managing the chronic autoimmune condition. 该装置向受影响地区提供定向电脉冲,旨在帮助减轻疼痛和炎症,避免药物的副作用。 The device, which delivers targeted electrical pulses to affected areas, is designed to help alleviate pain and inflammation without the side effects of pharmaceuticals. 它的核准反映了医疗技术的进步,并可能影响未来自发免疫疾病的治疗方法。 Its approval reflects progress in medical technology and could influence future treatment approaches for autoimmune diseases.